Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres Ejarque, Deborah Stocken, Zeynep Catak et al.|Nature Communications|2021Cited by 49
Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres Ejarque, Paola Di Meglio, Hira Bahadur Ale et al.|medRxiv|2020Cited by 2
Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres Ejarque, Deborah Stocken, Hira Bahadur Ale et al.|Nature Communications|2021Cited by 1